Rajesh Pradhan, MD
Cardiovascular Disease · Rapid City, SDNPI 1912115841
Payments from drug & device makers
Across 274 payments — averaging $6696.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$440K
- Boehringer Ingelheim International GmbH$364K
- Boehringer Ingelheim Pharma GmbH & Co.kg$347K
- Eli Lilly$290K
- Amgen$172K
- Novartis$142K
- plus $80K from 16 others
Across 1 payment — averaging $2799.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 109 | $440,297 |
| Boehringer Ingelheim International GmbH | 46 | $364,484 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 24 | $347,263 |
| Eli Lilly | 4 | $289,520 |
| Amgen | 5 | $171,615 |
| Novartis | 13 | $141,522 |
| AstraZeneca | 1 | $24,655 |
| Ionis Pharmaceuticals, Inc. | 15 | $23,330 |
| Alnylam Pharmaceuticals Inc. | 11 | $21,392 |
| Medtronic(2 entities) | 9 | $8,117 |
| Abbott | 10 | $1,767 |
| Boehringer Ingelheim | 2 | $193 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $188 |
| Regeneron Healthcare Solutions, Inc. | 3 | $143 |
| Pfizer | 3 | $132 |
| Chiesi USA, Inc. | 2 | $26 |
| Actelion Pharmaceuticals US, Inc. | 2 | $24 |
| Boston Scientific | 1 | $19 |
| Johnson & Johnson | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$1,834,738 in reported general payments places this provider in the 90th percentile of 33 cardiovascular disease providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Rapid City
- Drew PurdyRapid City$3.3M
- Bhaskar PurushottamRapid City$2.1M
- Alexander SchabauerRapid City$993K
- K HeilmanRapid City$289K
- Samuel DurrRapid City$133K
- Michael D'ursoRapid City$47K
- Amid BitarRapid City$1K
- Stephen WasemillerRapid City$961
- Lewis FerrierRapid City$84
- John BacharachSioux Falls$501K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.